TrialThe Journal of infectious diseases2020

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.

Bernard J C Macatangay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.